	Bowel ultrasound scan in the management of pediatric moderate ulcerative colitis: The applicability of international bowel ultrasound segmental activity score. J Pediatr Gastroenterol Nutr Di Benedetto M, Scarallo L, Pannacci C, Renzo S, Paci M, Naldini S, Barp J, Tasciotti L, Lionetti P. PMID: 42257284 [PubMed - as supplied by publisher]
	Histological activity predicts relapse in pediatric ulcerative colitis despite mucosal healing: a multicenter study from the pediatric IBD Porto group of ESPGHAN. J Crohns Colitis Trivi, Aloi M, Bramuzzo M, Chiantese C, D'Arcangelo G, Gattenlöhner S, Gianolio L, Granot M, H, Hussey S, Kang B, Kolho KL, de Laffolie J, Lega S, Martinelli M, Matar M, Mayer C, Miele E, Norsa L, Panarese I, Rinawi F, Rohani P, Romano C, Sansotta N, Scarallo L, Shouval DS, Staiano A, Strisciuglio C, Tomas D, Yerushalmy-Feler A, Zojaji R, Hojsak I. PMID: 42257255 [PubMed - in process]
	Efficacy of Upadacitinib Retreatment or Dose Escalation After Loss of Response in Ulcerative Colitis: Data From the Open-Label Extension of the U-ACTIVATE Study. Gastro Hep Adv Panaccione R, Colombel JF, Dubinsky M, Ma C, Kujawski M, Cheng E, Dubcenco E, Ogholikhan S, Barrachina EM, Hisamatsu T. PMID: 42254861 [PubMed]
	GPX7 marks fibroblast-associated stromal-innate immune crosstalk in ulcerative colitis. Front Immunol He J, Chen R, Qiu S, Li P, Gao X. PMID: 42253985 [PubMed - in process]
	Development of machine learning-based predictive models for fertility intentions in patients with Crohn's disease. Front Reprod Health Liu J, Bu J, Han X, Wang Z, Dong D, Wei M, Wu Q. PMID: 42253804 [PubMed]
	Effectiveness and safety of mirikizumab in patients with moderate-to-severe ulcerative colitis: the miri real multicenter study. J Crohns Colitis D'Amico F, Fanizzi F, Dal Buono A, Gabbiadini R, Nardone OM, Zilli A, Allocca M, Lauriola GM, Jairath V, Peyrin-Biroulet L, Fiorino G, Castiglione F, Massimino L, Mastronardi M, Armuzzi A, Danese S. PMID: 42252131 [PubMed - in process]
	Swertiamarin promotes barrier function to alleviate ulcerative colitis by inducing autophagy via the PI3K/AKT/mTOR-signaling pathway. Int Immunopharmacol Ma Y, Gong H, Wei N, Lu T, Yin W, Wei J, Gou L, Wang R, Zhang D. PMID: 42251831 [PubMed - as supplied by publisher]
	Emerging small molecules for ulcerative colitis: clinical advancements and trial insights. Expert Opin Emerg Drugs Lanzotti C, Fanizzi F, D'Amico F, Zilli A, Furfaro F, Allocca M, Solitano V, Cicerone C, Massironi S, Parigi TL, Peyrin-Biroulet L, Danese S. PMID: 42251531 [PubMed - as supplied by publisher]
	An Interpretable CT-based Prediction Model Assists in Predicting Length of Stay in Ulcerative Colitis Patients: A Multicenter Study. Acad Radiol Lu J, Zhao H, Li J, Xu H, Zhang J, Cheng T, Guo J, Han X, Wang Y, Meng X, Jiang J, Sun H, Wang Z, Xu L, Cui J, Yang Z. PMID: 42248758 [PubMed - as supplied by publisher]
	Position statement of the spanish working group on crohn's disease and ulcerative colitis (geteccu) on the diagnosis and management of acute severe ulcerative colitis. Gastroenterol Hepatol Ordás I, Caballol B, Giordano A, Esteve M, Rodríguez-Moranta F, Bravo R, Trabal J, Segú X, Menchén L, Casbas AG, Zabana Y. PMID: 42248446 [PubMed - as supplied by publisher]
	Comparing Onset of Efficacy of Biologic and Small Molecule Therapies in Biologic-NaÃ¯ve Ulcerative Colitis: A Post-hoc Analysis. Clin Gastroenterol Hepatol Wong ECL, Jairath V, Dulai PS, Marshall JK, Ma C, Reinisch W, Narula N. PMID: 42248438 [PubMed - as supplied by publisher]
	The Efficacy and Safety of Etrasimod in Mildly to Moderately Active Ulcerative Colitis: Results from the Phase 2 GLADIATOR Trial. Clin Gastroenterol Hepatol Danese S, Goetsch M, Peyrin-Biroulet L, Yarur AJ, Dubinsky M, Rubin DT, Feagan BG, D'Haens G, Baert F, Lazin K, Gu G, Yu J, Lawendy N, Zang C, Wang W, Menon S, Law EH, Modesto I, Wosik K, Sidhu S, Niezychowski W, Vermeire S. PMID: 42248437 [PubMed - as supplied by publisher]
	Abbreviated non-contrast magnetic resonance enterography for Crohn's disease: a reliability study. Radiol Med Caliendo V, Patanè V, Marinelli L, Russo A, Brunese MC, Selvaggi F, Gravina AG, Cappabianca S, Reginelli A. PMID: 42247026 [PubMed - as supplied by publisher]
	An observational cohort study evaluating adalimumab concentrations for predicting non-recapture of biochemical response after dose escalation in patients with Crohn's disease experiencing secondary loss of response. J Can Assoc Gastroenterol De Marco D, McHugh K, Plamondon S, Rioux LC, Steinhart AH, Horvat M, Afif W. PMID: 42244850 [PubMed]
	Objective assessment of physical activity using wearable devices in patients with mild-to-moderate Crohn's disease. J Can Assoc Gastroenterol Toews B, Raman M, Ferber R, Lu C, Reimer RA. PMID: 42244848 [PubMed]
	Rare Complications in Crohn's Disease: Diagnostic and Therapeutic Challenge of Dermal Abscesses Caused by Nontuberculous Mycobacteria Following Infliximab Therapy, and Fluoroquinolone-Related Achilles Tendon Rupture. Am J Case Rep Gupta N, Yadav K, Carter A, Karimian B, Almonte C, Sampath R. PMID: 42244158 [PubMed - in process]
	Gut-reproduction axis: genome-wide pleiotropic and prospective evidence linking inflammatory bowel disease with gynecological disorders. Inflamm Res Jiang Z, Yu X, Lu H, Su M, Li X, Su Q, Wang L, Jin J, Jin Y. PMID: 42243339 [PubMed - indexed for MEDLINE]
	Re: Palmela et al. Use of Intestinal Ultrasound in a Tight Monitoring Approach in Crohn's Disease: A Multicentre Prospective Study. Clin Gastroenterol Hepatol Toth E, Koulaouzidis A. PMID: 42242662 [PubMed - as supplied by publisher]
	Plasma Phospholipids and Incident Ulcerative Colitis: A Prospective Cohort Study in the UK Biobank. Clin Transl Gastroenterol Tang J, Zhou D, Liu S. PMID: 42241831 [PubMed - as supplied by publisher]
	Efficacy and safety of risankizumab in moderate-to-severe Crohn's disease: a systematic review and meta-analysis. Ther Adv Gastroenterol Nasim H, Siddiqui AH, Khan SJ, Fatima K, Naz A, Yousafzai ZA, Malik J, Naeem N, Khan U, Mahato RK. PMID: 42239823 [PubMed]

Articles 1 - 20 / 57815

Page 1 of 2891



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy